• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人GITRL在髓样树突状细胞上的表达增强了它们的免疫刺激功能,但并未消除CD4+CD25+调节性T细胞的抑制作用。

Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells.

作者信息

Tuyaerts Sandra, Van Meirvenne Sonja, Bonehill Aude, Heirman Carlo, Corthals Jurgen, Waldmann Herman, Breckpot Karine, Thielemans Kris, Aerts Joeri L

机构信息

Laboratory of Molecular and Cellular Therapy, Department of Physiology and Immunology, Medical School of the Vrije Universiteit Brussel, Laarbeeklaan 103/E, 1090 Brussels, Belgium.

出版信息

J Leukoc Biol. 2007 Jul;82(1):93-105. doi: 10.1189/jlb.0906568. Epub 2007 Apr 20.

DOI:10.1189/jlb.0906568
PMID:17449724
Abstract

CD4(+)CD25(+) regulatory T cells (Treg) have been described as an important hurdle for immunotherapy. Engagement of glucocorticoid-induced TNF receptor-related protein (GITR) has emerged recently as an important mechanism to control the suppression of CD4(+)CD25(+) Treg. Furthermore, it has been documented extensively that GITR ligation is costimulatory for naive and activated T cells in the murine setting. However, little is known about the role of the human GITR ligand (huGITRL). We wanted to explore whether huGITRL could enhance antigen-specific T cell priming by dendritic cells (DC). First, we confirmed the endogenous expression of GITRL on HUVEC. We also detected GITRL expression on EBV-B cell lines, whereas no GITRL expression was observed on human monocyte-derived DC. Electroporation of GITRL mRNA in monocyte-derived DC resulted in a strong and long-lasting surface expression of GITRL. In contrast to data obtained in mice, no significant abrogation of Treg suppression by GITRL-expressing human DC was observed. Consistent with our mouse data, we showed that huGITRL is costimulatory for responder T cells. Furthermore, we found that GITRL-expressing DC primed increased numbers of Melan-A-specific CD8(+) T cells. We conclude that although huGITRL is not capable of alleviating Treg suppression of responder T cells, huGITRL overexpression on monocyte-derived DC enhances their capacity to induce antigen-specific T cell responses. Thus, GITRL incorporation in DC might improve the antitumor immune response after vaccination.

摘要

CD4(+)CD25(+)调节性T细胞(Treg)被认为是免疫治疗的一个重要障碍。糖皮质激素诱导的TNF受体相关蛋白(GITR)的参与最近已成为控制CD4(+)CD25(+) Treg抑制作用的重要机制。此外,已有大量文献记载,在小鼠模型中,GITR连接对幼稚和活化的T细胞具有共刺激作用。然而,关于人GITR配体(huGITRL)的作用却知之甚少。我们想探讨huGITRL是否能增强树突状细胞(DC)介导的抗原特异性T细胞启动。首先,我们证实了GITRL在人脐静脉内皮细胞(HUVEC)上的内源性表达。我们还检测到EBV-B细胞系上有GITRL表达,而在人单核细胞来源的DC上未观察到GITRL表达。将GITRL mRNA电穿孔导入单核细胞来源的DC后,可导致GITRL在细胞表面强烈且持久地表达。与在小鼠中获得的数据相反,未观察到表达GITRL的人DC对Treg抑制作用有明显的消除作用。与我们在小鼠中的数据一致,我们发现huGITRL对反应性T细胞具有共刺激作用。此外,我们发现表达GITRL的DC启动了更多数量的Melan-A特异性CD8(+) T细胞。我们得出结论,尽管huGITRL不能减轻Treg对反应性T细胞的抑制作用,但单核细胞来源的DC上过表达huGITRL可增强其诱导抗原特异性T细胞反应的能力。因此,将GITRL整合到DC中可能会改善疫苗接种后的抗肿瘤免疫反应。

相似文献

1
Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells.人GITRL在髓样树突状细胞上的表达增强了它们的免疫刺激功能,但并未消除CD4+CD25+调节性T细胞的抑制作用。
J Leukoc Biol. 2007 Jul;82(1):93-105. doi: 10.1189/jlb.0906568. Epub 2007 Apr 20.
2
GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory.GITR 配体融合蛋白激动剂增强了肿瘤抗原特异性 CD8 T 细胞应答,并导致持久的记忆。
J Immunother Cancer. 2017 Jun 20;5:47. doi: 10.1186/s40425-017-0247-0. eCollection 2017.
3
Dendritic cells engineered to express GITRL enhance therapeutic immunity in murine Lewis lung carcinoma.经工程改造表达 GITRL 的树突状细胞增强了小鼠 Lewis 肺癌的治疗性免疫。
Cancer Lett. 2011 Feb 28;301(2):142-50. doi: 10.1016/j.canlet.2010.11.005. Epub 2010 Dec 24.
4
Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.WGP 通过上调树突状细胞上的 GITRL 提高了小鼠 Lewis 肺癌的抗肿瘤免疫。
PLoS One. 2012;7(10):e46936. doi: 10.1371/journal.pone.0046936. Epub 2012 Oct 15.
5
Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumours.通过肿瘤上异位表达的糖皮质激素诱导的肿瘤坏死因子受体相关受体配体(GITRL)增强T细胞介导的抗肿瘤免疫。
Immunology. 2009 Aug;127(4):489-99. doi: 10.1111/j.1365-2567.2008.03036.x.
6
Low-Dose LPS Induces Tolerogenic Treg Skewing in Asthma.低剂量 LPS 诱导哮喘中耐受性 Treg 的偏向。
Front Immunol. 2020 Sep 23;11:2150. doi: 10.3389/fimmu.2020.02150. eCollection 2020.
7
GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells.糖皮质激素诱导肿瘤坏死因子受体配体共刺激激活CD4+T细胞的效应和调节功能。
Biochem Biophys Res Commun. 2008 May 16;369(4):1134-8. doi: 10.1016/j.bbrc.2008.03.024. Epub 2008 Mar 17.
8
The GITRL-GITR system alters TLR-4 expression on DC during fungal infection.在真菌感染期间,GITRL-GITR系统会改变树突状细胞上TLR-4的表达。
Cell Immunol. 2009;257(1-2):13-22. doi: 10.1016/j.cellimm.2009.02.001. Epub 2009 Mar 9.
9
Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells.鉴定在树突状细胞中组成性表达的糖皮质激素诱导的肿瘤坏死因子受体的一种配体。
Biochem Biophys Res Commun. 2003 Oct 17;310(2):433-8. doi: 10.1016/j.bbrc.2003.09.024.
10
Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.抗糖皮质激素诱导肿瘤坏死因子受体(GITR)激动剂疗法本质上可增强CD8 T细胞对慢性淋巴细胞性脉络丛脑膜炎病毒(LCMV)的反应,从而规避LCMV诱导的抗原呈递细胞(APC)上共刺激分子GITR配体的下调。
J Immunol. 2014 Nov 15;193(10):5033-43. doi: 10.4049/jimmunol.1401002. Epub 2014 Oct 3.

引用本文的文献

1
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations.树突状细胞疫苗:从传统方法到新一代的转变。
Cells. 2023 Aug 25;12(17):2147. doi: 10.3390/cells12172147.
2
An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8 T cells.一种 mRNA 混合物将树突状细胞重新定向为抗病毒程序,诱导抗癌细胞毒性干细胞和中央记忆 CD8 T 细胞。
Front Immunol. 2023 Feb 13;14:1111523. doi: 10.3389/fimmu.2023.1111523. eCollection 2023.
3
In or out of control: Modulating regulatory T cell homeostasis and function with immune checkpoint pathways.
在控制之内还是之外:通过免疫检查点途径调节调节性 T 细胞的稳态和功能。
Front Immunol. 2022 Dec 15;13:1033705. doi: 10.3389/fimmu.2022.1033705. eCollection 2022.
4
RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System.RNA 在癌症免疫疗法中的作用:解锁免疫系统的潜力。
Clin Cancer Res. 2022 Sep 15;28(18):3929-3939. doi: 10.1158/1078-0432.CCR-21-3304.
5
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course.核因子κB受体激活剂(RANK)赋予急性髓系白血病对化疗的抗性并与不良病程相关。
Cancers (Basel). 2021 Dec 4;13(23):6122. doi: 10.3390/cancers13236122.
6
mRNA therapeutics in cancer immunotherapy.mRNA 疗法在癌症免疫治疗中的应用。
Mol Cancer. 2021 Apr 15;20(1):69. doi: 10.1186/s12943-021-01348-0.
7
Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy.利用常规树突状细胞的全部功能进行癌症免疫治疗。
Pharmaceutics. 2020 Jul 14;12(7):663. doi: 10.3390/pharmaceutics12070663.
8
Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis.贝利尤单抗中和(NK 细胞来源的)B 细胞激活因子可恢复慢性淋巴细胞白血病细胞对直接和利妥昔单抗诱导的 NK 细胞溶解的敏感性。
Leukemia. 2015 Aug;29(8):1676-83. doi: 10.1038/leu.2015.50. Epub 2015 Feb 24.
9
Update on vaccine development for renal cell cancer.肾细胞癌疫苗研发进展
Open Access J Urol. 2010 Aug 4;2:125-41. doi: 10.2147/rru.s7242.
10
Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma.糖皮质激素诱导的 TNF 受体 GITR 在多发性骨髓瘤中的新型肿瘤抑制功能。
PLoS One. 2013 Jun 13;8(6):e66982. doi: 10.1371/journal.pone.0066982. Print 2013.